Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 5/2015

01.10.2015 | Original Article

Effectiveness of Early Infant Diagnosis (EID) in Detecting the Serostatus of HIV-Exposed Infants and Children

verfasst von: Mariam Khanam, Sebanti Goswami, Partha Mukhopadhyay

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background/purpose of the study

Although interventions to prevent mother-to-child transmission of HIV infection are being increasingly implemented as a part of national guideline, the prevalence of pediatric HIV remains high. There is remarkable increase in survival if HIV-infected children have access to early infant diagnosis (EID) and treatment.

Methods

The study was conducted in the Department of Obstetrics and Gynecology Medical College, Kolkata from July 2011 to February 2014 after obtaining approval from the institutional ethics committee. All the infants of HIV-positive mothers who came for EID between 6 weeks to 18 months of age during the study period were included in the study. A total number of 151 infants were included in the study and divided into Group A and B according to the time of first testing. It was a prospective observational longitudinal study. Data were collected from the EID register of PPTCT unit Medical College Kolkata. EID was done as laid out in the pediatric ART (anti-retroviral therapy) guidelines of the National AIDS Control Organization.

Results

Effectiveness of EID is judged by the corroboration of results at 6 week, 6 and 18 months. Comparing the results in group A, we found that 10.26, 8.41, and 7.29 % were positive at 6 weeks, 6 and 18 months, respectively, and with p value of 0.5828 the differences were not statistically significant. In group B, we observed that 47.06 and 45.45 % were positive at 6 and 18 months, respectively. Analysis revealed a p value of 0.9072 indicating no significant statistical difference between the results of testing in different periods. This reflects a good correlation between the 6 weeks, 6 and 18 months value, thus establishing the integrity of the EID.

Conclusion

Ultimate integrity of the PPTCT is judged by testing the child. EID is a novel procedure which aims at earlier diagnosis and initiation of treatment in the children.
Literatur
2.
Zurück zum Zitat Guidelines for HIV care and treatment in infants and children NACO. 2006;3: 9–11. Guidelines for HIV care and treatment in infants and children NACO. 2006;3: 9–11.
3.
Zurück zum Zitat Little K, Thorne C, Luo C, et al. Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: Reviewing the need for HIV treatment. Curr HIV Res. 2007;5:139–53.CrossRefPubMed Little K, Thorne C, Luo C, et al. Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: Reviewing the need for HIV treatment. Curr HIV Res. 2007;5:139–53.CrossRefPubMed
4.
Zurück zum Zitat Patton JC, Sherman GG, Coovadia AH, et al. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol. 2006;13:152–5.PubMedCentralCrossRefPubMed Patton JC, Sherman GG, Coovadia AH, et al. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol. 2006;13:152–5.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Fischer A, Lejczak C, Lambert C, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol. 2004;42:16–20.PubMedCentralCrossRefPubMed Fischer A, Lejczak C, Lambert C, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol. 2004;42:16–20.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Lukong CS, Tshimwanga Ed, Mfuh YA. The role of PCR in early diagnosis of Human immunodeficiency virus infection in infants. Ann Afr med. 2013;12(4):232–5.CrossRefPubMed Lukong CS, Tshimwanga Ed, Mfuh YA. The role of PCR in early diagnosis of Human immunodeficiency virus infection in infants. Ann Afr med. 2013;12(4):232–5.CrossRefPubMed
Metadaten
Titel
Effectiveness of Early Infant Diagnosis (EID) in Detecting the Serostatus of HIV-Exposed Infants and Children
verfasst von
Mariam Khanam
Sebanti Goswami
Partha Mukhopadhyay
Publikationsdatum
01.10.2015
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 5/2015
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-014-0632-2

Weitere Artikel der Ausgabe 5/2015

The Journal of Obstetrics and Gynecology of India 5/2015 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.